The Russian developer, manufacturer and distributor of test systems for laboratory diagnostics by enzyme immunoassay, immunochemiluminescence analysis and molecular genetic studies by polymerase chain reaction seeks distributors

CommercialRuskoBORU20210408005
Offers
Summary: 
A Russian company specializing in bio and chemical technology has developed a test system for laboratory diagnostics by enzyme immunoassay, immunochemiluminescence analysis and molecular genetic studies by polymerase chain reaction. The company is looking for partners to conclude a distribution services agreement
Description: 
The Russian company from St. Petersburg was founded in 1992. For about 30 years, the company has become a successful developer in the field of bio and chemical technology not only in Russia, but also in many countries of the world . The company's engineers have extensive experience in the development of test systems for laboratory diagnostics. The main activity of the company are: development, production and implementation of test systems for laboratory diagnostics by enzyme-linked immunosorbent assay (ELISA), immunochemiluminescence analysis (ICLA) and molecular genetic studies by the polymerase chain reaction (PCR) method; development and production of closed-type equipment for laboratory research: automatic immunochemical chemiluminescent analyzer with accessories. The main products are: Test systems for laboratory diagnostics by ELISA * Assortment group “Hormonal diagnostics. Tumor markers " • Optimum incubation time from 30 to 120 minutes • High sensitivity of test systems • Standardized test conditions + 37 °C with shaking guarantee the reliability of the result • Wide ranges of detectable concentrations allow detection of normal and abnormal hormone concentrations. And for a number of positions - the widest among analogues • Long shelf life of kits from 12 to 18 months • Shelf life of kits after opening is from 1 to 6 months (depending on the test system) * Assortment group "Infectious Diagnostics" • short analysis time: from 30 minutes to 1 hour 15 minutes; • diagnostic specificity of the kits is not less than 98.5% - 100%; • diagnostic sensitivity of the kits is not less than 98.5% -100%. • similar analysis schemes are convenient for performing studies both in manual mode and on automatic ELISA analyzers; • complete sets for 96, 192, 480 and 960 determinations allow the use of test systems for laboratories with a different flow of research. * PCR (polymerase chain reaction) - diagnostics (isolation kits, transport media, diagnostics of STDs (sexually transmitted diseases), SARS-CoV-2, viral infections, congenital adrenal dysfunction) • Tests are designed in accordance with WHO (World Health Organization) recommendations: use of endogenous internal control and 3 targets for detecting SARS-CoV-2 • Completion of kits with reagents for detection and isolation of RNA (ribonucleic acid) virus • convenient and reliable in use, as the reaction mixture is pipetted into individual or striped paraffin tubes to provide a hot start • are characterized by a single amplification program • include positive, negative and internal controls, which allows to assess the quality of the production. • Designed for 112 determinations - the maximum among analogs. * DNA microarrays • High diagnostic sensitivity - the set detects 28 mutations, 99% specific for Russia and the CIS • Early diagnosis allows to start treatment as early as possible • The diagnosis is made quickly and unambiguously • Dry blood spots can be used as biological material, not only whole blood and scrapings of the buccal epithelium Multiplex analysis - reduces analysis time • DNA card and DNA archive for collection and storage of DNA Convenience of collection, transportation and storage of samples at up to + 25 ° C for up to 4 years. The Russian company is looking for foreign partners to conclude a distribution services agreement. The company wants to expand abroad with growing production and therefore they wish to find new partners - distributors, capable to roll out the products on their markets, based on distribution agreements. The company would like to establish a long-term cooperation. The company is interested in working with the structures of the Ministry of Health, hospitals, hospitals, scientific and medical centers, clinical diagnostic laboratories (public and private). The company is ready to supply its products to these partners.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
Type: Structures of the Ministry of Health, hospitals, hospitals, scientific and medical centers, clinical diagnostic laboratories (public and private). Role: Under the distribution agreement, the Russian company will supply the necessary equipment to the partner for the subsequent sale. The company is ready to provide its partner with the necessary products. The partner, in turn, must provide the geography of product distribution, relevant documentation and information.
Stage of Development: 
Already on the market
External code: 
BORU20210408005